Virtus Peptides is a US research-peptide vendor based in AZ that lists 5 injectable peptides, including Tirzepatide, Retatrutide and BPC-157. Across 5 products with a market median, its prices sit 46% below the median for the same peptide and vial size; it is the cheapest vendor we track on Tirzepatide and Retatrutide. We found certificates for most of the in-stock products we track. Based on the certificates our crawler found; vendors may publish more than we index. Shipping is $5 and free over $200; it accepts card, Zelle and ACH.
Facts extracted from the vendor’s site and not yet reviewed by us.
COA coverage: Broad
We found certificates for most of the in-stock products we track. Based on the certificates our crawler found; vendors may publish more than we index.
from 8 indexed documents
current certificates, by the date printed on them
Vanguard Laboratory signs the most of them
oldest Aug 7, 2026
The site names Vanguard Laboratory, ILS Laboratories as its testing labs. These are the vendor’s own flags, not our measurements.
Virtus Peptides says every batch undergoes 9 tests (including HPLC, ICP-MS, sterility, endotoxin, residual solvents, and fentanyl screening) via Vanguard Laboratory, an ISO/IEC 17025-accredited lab, requiring ≥99% peptide purity before release.
$2.90/mg median
Unchanged
Median price per mg across Virtus Peptides’s 1-6 priced listings, from Sep 8 ($2.90/mg) to Oct 23 ($2.90/mg) over 44 observed days. The mix of products behind the median changes as listings come and go, so this tracks the catalog as well as the prices.
Listed prices at Virtus Peptides against the median price per mg for the same peptide at the same vial size, across every vendor we track. Vendors change prices without notice, so check the current listing before you order.
Below the market median on 5 of 5 comparable listings, above it on 0. Typical listing: 46% below market.
International
46% below
vs market median
5
peptides
Broad
in-stock products
Oct 23
International
3% above
vs market median
52
peptides
Partial
in-stock products
Oct 23
International
5% above
vs market median
24
peptides
Broad
in-stock products
Oct 22
International
4% below
vs market median
46
peptides
None found
in-stock products
Oct 12
Virtus Peptides sits 46% below market the tracked market median on matched peptide/size rows. The catalog in this index is smaller than Nationwide Peptides's. On COA coverage, Virtus Peptides rates broad and Nationwide Peptides rates partial. Based on the certificates our crawler found; vendors may publish more than we index.
The honest comparison unit is price per mg on matched peptide/size rows. COA coverage is presence of a current indexed document, not purity-as-quality. See the Evidence Atlas and how to read a COA.
Evidence boundary: Listed prices, stock signals, and indexed COA documents are observations. They do not establish legitimacy, authenticity, safety, sterility, chain of custody, product quality, fulfillment, or suitability. No vendor is endorsed.
Pricing data cannot settle that question, and we do not test products or verify fulfillment. Here is the evidence we do hold for Virtus Peptides. We found certificates for most of the in-stock products we track. Those certificates were signed by 2 labs, the newest tested October 16, 2026. Based on the certificates our crawler found; vendors may publish more than we index. We have been recording their prices since September 8, 2026. Read each certificate yourself, check that its lot and compound match what you are buying, and treat anything we have not recorded as unknown rather than as an answer.
We found certificates for most of the in-stock products we track. The freshest was tested October 16, 2026. Based on the certificates our crawler found; vendors may publish more than we index. We have not recorded a testing or COA page on their site. A certificate on file records what a document says; it cannot prove chain of custody or what is in the vial you receive.
Virtus Peptides states that orders ship from Arizona. This is what the vendor says about itself, not something we have verified.
Virtus Peptides lists shipping at $5. Orders over $200 are listed as shipping free. Checkout is the only place these figures are binding.
At the time we recorded it, Virtus Peptides listed credit or debit card, Zelle and ACH bank transfer. Peptide storefronts change processors often, so the options at checkout may differ from what we hold.
We have none on record for Virtus Peptides. When a code we can verify appears, it shows on this page and the prices here are adjusted for it; until then, every figure on this page is the list price.
Across 5 graded products, Virtus Peptides's median price per mg sits 46.3% below the median for the same peptide at the same vial size. We track 5 products from them in total. Price per mg is the comparison unit: a cheaper vial holding less is not a cheaper product.
Product documentation
Across the tracked peptide products we hold for Virtus Peptides, COA coverage rates broad. The public index contains 8 documents. Reported test dates in this set run from Aug 7, 2026 through Oct 16, 2026. That rating covers the full tracked catalogue for Virtus Peptides, including products that are currently out of stock, so it can differ from the in-stock rating above. Based on the certificates our crawler found; vendors may publish more than we index.
across the full tracked catalogue
current certificates, by the printed test date.
Printed date is over 18 months old.
Named on more current records than any other lab.
Certificate assessment
3 evaluated certificates
3 graded · 0 not graded · 2 in the A range.
The sample prioritizes up to ten popular peptides from this vendor. Grades assess the document and its reported tests, not the vendor’s whole catalog or the safety of a product.
Automated checks can make mistakes. Open “Why this result?” for the reason and any review notice, and check the linked COA’s lot against your product. How grading works
3 evaluated records
Document grade
X2: The certificate's identity evidence (HPLC-UV/VIS) can't confirm the peptide on its own; that needs mass spectrometry or a side-by-side match to a reference standard.
Document check: fail.
Lab record: not confirmed.
Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2
ZQ-20260809-TSM10-GREEN
Document grade
C3: We couldn't confirm this certificate against the lab's own records, so the grade stops at A-.
Document check: flag.
Lab record: not confirmed.
Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2
ZQ-20260805-BPC10-BLUE
Document grade
C3: We couldn't confirm this certificate against the lab's own records, so the grade stops at A-.
Document check: flag.
Lab record: not confirmed.
Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2
ZQ-20260715 | RT10-BLUE
| COA grade | Printed lab | Certificate | |||
|---|---|---|---|---|---|
| Tesamorelin Lot: ZQ-20260809-TSM10-GREEN | Document grade Why this result?X2: The certificate's identity evidence (HPLC-UV/VIS) can't confirm the peptide on its own; that needs mass spectrometry or a side-by-side match to a reference standard. Document check: fail. Lab record: not confirmed. Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2 | Vanguard Laboratory | Sep 14, 2026 | No purity printed | View COA |
| BPC-157 Lot: ZQ-20260805-BPC10-BLUE | Document grade Why this result?C3: We couldn't confirm this certificate against the lab's own records, so the grade stops at A-. Document check: flag. Lab record: not confirmed. Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2 | Vanguard Laboratory | Sep 7, 2026 | No purity printed | View COA |
| Retatrutide Lot: ZQ-20260715 | RT10-BLUE | Document grade Why this result?C3: We couldn't confirm this certificate against the lab's own records, so the grade stops at A-. Document check: flag. Lab record: not confirmed. Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2 | ILS Laboratories | Aug 7, 2026 | 99.88%99.5%+ | View COA |
4 current records
KPV10-001
ZQ-20260809-TSM10-GREEN
ZQ-20260805-BPC10-BLUE
ZQ-20260715 | RT10-BLUE
| Printed lab | Certificate | |||
|---|---|---|---|---|
| KPV | Vanguard Laboratory | Oct 16, 2026 | 99.19%99.0–99.49% | View COA |
| Tesamorelin | Vanguard Laboratory | Sep 14, 2026 | No purity printed | View COA |
| BPC-157 | Vanguard Laboratory | Sep 7, 2026 | No purity printed | View COA |
| Retatrutide | ILS Laboratories | Aug 7, 2026 | 99.88%99.5%+ | View COA |
A record appears on file after our pipeline identifies the document as a certificate of analysis and matches its printed compound to a catalog peptide. The record cannot prove authenticity, chain of custody, sterility, product safety, or suitability for use.
These are counts of documents in our index, and a coverage rating of what our crawler found. They do not grade vendor quality, legitimacy, or safety. Printed fields can contain transcription errors. “Older record” means the reported test date is more than 18 months old.
See the testing methodology and dataset, or compare this coverage against another vendor in the vendor comparison tool.
The Peptide App. Virtus Peptides peptide prices, COA coverage and vendor facts. Updated October 23, 2026. https://www.thepeptide.app/pricing/vendor/virtus-peptides
The Peptide App. (2026). Virtus Peptides peptide prices, COA coverage and vendor facts. Retrieved from https://www.thepeptide.app/pricing/vendor/virtus-peptides
Prices and certificate counts on this page were last refreshed October 23, 2026.
